Artiva Biotherapeutics said it will eviscerate its workforce 94% and evaluate strategic options after two patients treated ...

Uduak Thomas, Senior Editor at GEN, took a minute away from the talks, posters, and expo hall to join Julianna LeMieux, PhD, ...

Study uncovers the Vanin-pantethine-cholesterol axis as a key metabolic pathway governing dendritic cell activation.

Anthropic plans to expand its growing presence in life sciences by investing further in knowledge, talent, partnerships, and ...

In this GEN webinar, Bernd Bodenmiller, PhD (University of Zürich), illustrates this integrated approach through two recent examples.

Scaling the science into any kind of business “is just really tough, but scaling a biotechnology company in South Africa is ...

Closing the execution gap is one of the greatest opportunities biopharma has today to enhance resilience and unlock the full ...

The collective activity of all six genes, which the researchers called the PHFScore, divided patients into groups with ...

An entity of Swedish private equity firm EQT has agreed to acquire Qiagen for €10.8 billion (about $12.1 billion) cash, both said today, in a deal that would take private the global life-sciences ...

The University of Washington School of Medicine Institute for Protein Design (IPD) has partnered with Nvidia to develop an ...

ASHG President Susan Slaugenhaupt, PhD, opened the society’s Montreal meeting with a heartfelt address of hope, leadership, ...

In this GEN webinar, our expert speaker Josh Wheeler, MD, PhD, will discuss a biology-first, interpretable AI approach to ...